Highly reduced survival in essential thrombocythemia and polycythemia vera patients with vascular complications during follow-up.

The risk of vascular complications is high in both ET and PV, and these complications have a considerable impact on life expectancy. The protective effect of anti-thrombotic and cytoreductive therapy for vascular complications in PV underscores the importance of avoiding undertreatment.